Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,832,443 papers from all fields of science
Search
Sign In
Create Free Account
bectumomab
Known as:
IMMU-LL2-Fab
, MAb LL2 (EPB2)
, monoclonal antibody IMMU-LL2-Fab
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
LymphoSCAN
Broader (1)
Monoclonal Antibodies
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Commentary: Basic Research in HIV Vaccinology Is Hampered by Reductionist Thinking
Mike R. King
Frontiers in Immunology
2016
Corpus ID: 31337989
Structure-based reverse vaccinology (RV) (Van Regenmortel 2011a) attempts to develop an HIV-1 vaccine by determining the 3-D…
Expand
2008
2008
Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
T. Page
,
R. Woodward
Health Care Financing Review
2008
Corpus ID: 4131575
On January 1, 2000, Medicare extended the coverage of immunosuppression medications from 3 years to life for elderly and disabled…
Expand
Review
2008
Review
2008
Immune-based disorders: the challenges for translational immunology
D. Pozo
Journal of Cellular and Molecular Medicine
2008
Corpus ID: 19218126
Our immune system constantly interacts with our internal environment, protects us from our external environment and provides the…
Expand
Highly Cited
2004
Highly Cited
2004
BROAD ANTIRETROVIRAL DEFENSE BY HUMAN APOBEC3G THROUGH LETHAL EDITING OF NASCENT REVERSE TRANSCRIPTS
J. Church
Pediatrics
2004
Corpus ID: 59076652
Mangeat B, Turelli P, Caron G, et al. Nature. 2003;424:99–102 Innate intracellular antiretroviral defense mechanisms have been…
Expand
2003
2003
Health protection and a new strategy for combating infection in children
E. Davies
,
M. Sharland
,
A. Nicoll
Archives of Disease in Childhood
2003
Corpus ID: 44611050
A unique opportunity to develop world class infection and health protection services for children The Chief Medical Officer (CMO…
Expand
2002
2002
Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL).
D. Lamonica
,
M. Czuczman
,
H. Nabi
,
D. Klippenstein
,
Z. Grossman
Cancer Biotherapy and Radiopharmaceuticals
2002
Corpus ID: 20513561
UNLABELLED The efficacy of a Tc99m-labeled anti-lymphoma antibody fragment, bectumomab [LymphoScan], was retrospectively examined…
Expand
1996
1996
Norwegian scabies complicated by fatal brain abscess in a renal transplant patient.
H. Mansy
,
A. Somorin
,
M. El-Sherif
,
C. Eze
,
S. Al-Dusari
,
P. Filobbos
Nephron
1996
Corpus ID: 3307079
Dr. Hatem Mansy, Senior Consultant Nephrologist, North West Armed Forces, Hospitals Program, Tabuk (Saudi Arabia) Dear Sir…
Expand
Review
1996
Review
1996
Short term immunosuppressive therapy and long-term immunoregulation: promises and problems.
John D. Isaacs
,
A. Dick
British Journal of Ophthalmology
1996
Corpus ID: 15345982
Review
1992
Review
1992
Overview: NCI Workshop on Investigational Strategies for Detection and Intervention in Early Lung Cancer.
J. Mulshine
Cancer Research
1992
Corpus ID: 32911895
The reason why the NCI Workshop on Investigational Strat egies for Detection and Intervention in Early Lung Cancer was convened…
Expand
1990
1990
Immunisation in Fife Part II — Failure to immunise against whooping cough — reasons given by parents
H. Barlow
,
D. Walker
1990
Corpus ID: 72210109
IN this study in part of Fife, parents of children under 5 were interviewed about pertussis immunisation. Fifteen per cent of the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE